Study Summary
The efficacy of advanced pancreatic cancer and gastric cancer needs to be further improved. Claudin is a kind of integrin membrane protein in the tight junction between epithelium and endothelium, which is highly expressed in gastric cancer and pancreatic cancer. Preclinical studies suggest that Claudin18.2CAR-T can effectively improve the remission rate of patients with advanced solid tumors.
Want to learn more about this trial?
Request More InfoInterventions
Claudin18.2 CAR-T cellsBIOLOGICAL
patients treated with Claudin18.2 CAR-T cells
Study Locations
| Facility | City | State | Country |
|---|---|---|---|
| Li Yu | Shenzhen | Guangdong | China |